Home »
Blog »
Sa1451 GLUCAGON-LIKE PEPTIDE-1 RECEPTOR AGONISTS USE DOES NOT INCREASE THE RISK FOR ACUTE PANCREATITIS AND IS ASSOCIATED WITH LOWER COMPLICATIONS IN PATIENTS WITH TYPE 2 DIABETES WHO DEVELOP ACUTE PANCREATITIS: A MULTI-CENTER ANALYSIS
Sa1451 GLUCAGON-LIKE PEPTIDE-1 RECEPTOR AGONISTS USE DOES NOT INCREASE THE RISK FOR ACUTE PANCREATITIS AND IS ASSOCIATED WITH LOWER COMPLICATIONS IN PATIENTS WITH TYPE 2 DIABETES WHO DEVELOP ACUTE PANCREATITIS: A MULTI-CENTER ANALYSIS
Sa1451 GLUCAGON-LIKE PEPTIDE-1 RECEPTOR AGONISTS USE DOES NOT INCREASE THE RISK FOR ACUTE PANCREATITIS AND IS ASSOCIATED WITH LOWER COMPLICATIONS IN PATIENTS WITH TYPE 2 DIABETES WHO DEVELOP ACUTE PANCREATITIS: A MULTI-CENTER ANALYSIS